Active Detection and Management of the Extension of Atherothrombosis in High Risk Coronary Patients In Comparison With Standard of Care for Coronary Atherosclerosis: The AMERICA Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Enrollment
- 526
- Locations
- 1
- Primary Endpoint
- death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Coronary artery disease is the first cause of death related to atherothrombosis.
Detailed Description
Coronary artery disease is the first cause of death related to atherothrombosis. There is a close correlation between the extension of coronary artery disease and the severity of atherosclerotic lesions in extra coronary arterial beds. In addition, these symptomatic extracoronary lesions dramatically decrease the survival of these patients. However, scant data are available regarding the prevalence of extracoronary asymptomatic lesions. Conversely, the annual absolute risk of these lesions remains unknown. Consequently, whether a systematic identification of these extracoronary asymptomatic lesions is relevant remains to be established. The Primary Objective and Primary Endpoint of the AMERICA study is to demonstrate the superiority of an active detection and management of the extension of atherothrombosis in high Risk coronary patients (active strategy) in comparison with standard of care for coronary atherosclerosis (conservative strategy).
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.
Time Frame: during the study
death (all cause) or any ischemic event leading to rehospitalisation or any evidence of organ failure.
Secondary Outcomes
- Incidence of each composite of the primary endpoint.(during the study)